US FDA Issues Two EUAs For Abbott, ELITechGroup Zika Tests
Executive Summary
FDA recently issued two Emergency Use Authorizations to two different device firms for their molecular-based Zika virus tests, including for Abbott Molecular's RealTime Zika Assay, and for ELITechGroup's Zika ELITe MGB Kit U.S.
You may also be interested in...
Quest Wins First Commercial Zika Test FDA Emergency-Use Approval
FDA approved the first emergency-use authorization for a commercially developed, molecular-based Zika virus diagnostics, developed by Quest's Focus Diagnostics subsidiary.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.